The supplemental new drug application for brexpiprazole in combination with sertraline is supported by data from three randomized clinical trials evaluating safety and efficacy in adult patients with post-traumatic stress disorder.
FDA Accepts Supplemental New Drug Application by Otsuka and Lundbeck for Combination Use of Brexpiprazole and Sertraline for Adults with Post-Traumatic Stress Disorder
Leave a comment
